NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...
While Google is sounding the trumpets on the transition from Universal Analytics to GA4, it is also beating the drum to herald new features for the venerable analytics platform. Collections are a set ...
Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights The Core Business (excluding COVID-19 related clinical testing and reagent revenues) exceeded once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback